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Background: MitraClip (Abbott Vascular, Menlo Park, California) is an effective low risk transcatheter treatment option for the treatment of 
functional mitral regurgitation (FMR). Pulmonary hypertension (PH) is a predictor of adverse outcome following mitral valve surgery. However, the 
prognostic implications of preoperative PH on FMR patients undergoing MitraClip procedure remain uncertain.
methods: Eighty-six FMR patients undergoing MitraClip procedure were divided into 2 groups; non-PH (n = 39) and PH group (n = 47). PH was 
defined as systolic pulmonary artery pressure (sPAP) greater than 50 mm Hg using Doppler transthoracic echocardiography.
results: The baseline sPAP in PH and non-PH groups were 64 ± 9 and 39 ± 10 mm Hg, respectively. Mean follow up was 520 ± 416 days. Acute 
procedural success was similar in both PH and non-PH groups (91.5% vs. 97.4%, p = NS). At 1-year follow up, sPAP significantly decreased in 
PH group (from 63 ± 8 mm Hg to 53 ± 15 mm Hg; p = 0.006), but not in non-PH group (from 38 ± 12 mm Hg to 37 ± 12 mm Hg; p = NS). The 
cumulative survival rate by Kaplan-Meier analysis (Figure 1) was 87.2% vs. 86.4% at 1-year, 53.3% vs. 82.6% at 2-year in PH and non-PH group, 
respectively (log-rank p = 0.005). In multivariable analyses, preoperative PH was associated with increased all-cause death (hazard ratio, 3.79; 95% 
confidence interval, 1.35-10.62; p = 0.011).
conclusions: Preoperative PH is a significant predictor of long-term survival after the MitraClip procedure for FMR.
 
